408 related articles for article (PubMed ID: 27197174)
21. Biochemical and structural insights into how amino acids regulate pyruvate kinase muscle isoform 2.
Nandi S; Dey M
J Biol Chem; 2020 Apr; 295(16):5390-5403. PubMed ID: 32144209
[TBL] [Abstract][Full Text] [Related]
22. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells.
Wu H; Li Z; Yang P; Zhang L; Fan Y; Li Z
Cell Signal; 2014 Nov; 26(11):2397-405. PubMed ID: 25041845
[TBL] [Abstract][Full Text] [Related]
23. Nuclear pyruvate kinase M2 complex serves as a transcriptional coactivator of arylhydrocarbon receptor.
Matsuda S; Adachi J; Ihara M; Tanuma N; Shima H; Kakizuka A; Ikura M; Ikura T; Matsuda T
Nucleic Acids Res; 2016 Jan; 44(2):636-47. PubMed ID: 26405201
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive analyses of the cysteine thiol oxidation of PKM2 reveal the effects of multiple oxidation on cellular oxidative stress response.
Irokawa H; Numasaki S; Kato S; Iwai K; Inose-Maruyama A; Ohdate T; Hwang GW; Toyama T; Watanabe T; Kuge S
Biochem J; 2021 Apr; 478(7):1453-1470. PubMed ID: 33749780
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of PKM2 Suppresses Tumor Growth and Invasion in Lung Adenocarcinoma.
Sun H; Zhu A; Zhang L; Zhang J; Zhong Z; Wang F
Int J Mol Sci; 2015 Oct; 16(10):24574-87. PubMed ID: 26501265
[TBL] [Abstract][Full Text] [Related]
26. Rocking cell metabolism: revised functions of the key glycolytic regulator PKM2 in cancer.
Chaneton B; Gottlieb E
Trends Biochem Sci; 2012 Aug; 37(8):309-16. PubMed ID: 22626471
[TBL] [Abstract][Full Text] [Related]
27. GRP78 is implicated in the modulation of tumor aerobic glycolysis by promoting autophagic degradation of IKKβ.
Li Z; Wang Y; Newton IP; Zhang L; Ji P; Li Z
Cell Signal; 2015 Jun; 27(6):1237-45. PubMed ID: 25748049
[TBL] [Abstract][Full Text] [Related]
28. PKM2 contributes to cancer metabolism.
Wong N; Ojo D; Yan J; Tang D
Cancer Lett; 2015 Jan; 356(2 Pt A):184-91. PubMed ID: 24508027
[TBL] [Abstract][Full Text] [Related]
29. TSP50 promotes the Warburg effect and hepatocyte proliferation via regulating PKM2 acetylation.
Gao F; Zhang X; Wang S; Zheng L; Sun Y; Wang G; Song Z; Bao Y
Cell Death Dis; 2021 May; 12(6):517. PubMed ID: 34016961
[TBL] [Abstract][Full Text] [Related]
30. Tumor M2-PK: A novel urine marker of bladder cancer.
Liu W; Woolbright BL; Pirani K; Didde R; Abbott E; Kaushik G; Martin P; Hamilton-Reeves J; Taylor JA; Holzbeierlein JM; Anant S; Lee EK
PLoS One; 2019; 14(6):e0218737. PubMed ID: 31246990
[TBL] [Abstract][Full Text] [Related]
31. Glucose restriction reverses the Warburg effect and modulates PKM2 and mTOR expression in breast cancer cell lines.
Tahtouh R; Wardi L; Sarkis R; Hachem R; Raad I; El Zein N; Hilal G
Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):26-33. PubMed ID: 31880514
[TBL] [Abstract][Full Text] [Related]
32. PKM2, a potential target for regulating cancer.
Li YH; Li XF; Liu JT; Wang H; Fan LL; Li J; Sun GP
Gene; 2018 Aug; 668():48-53. PubMed ID: 29775756
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic Kinase-Induced PKM2 Tyrosine 105 Phosphorylation Converts Nononcogenic PKM2 to a Tumor Promoter and Induces Cancer Stem-like Cells.
Zhou Z; Li M; Zhang L; Zhao H; Şahin Ö; Chen J; Zhao JJ; Songyang Z; Yu D
Cancer Res; 2018 May; 78(9):2248-2261. PubMed ID: 29440169
[TBL] [Abstract][Full Text] [Related]
34. Activators of PKM2 in cancer metabolism.
Warner SL; Carpenter KJ; Bearss DJ
Future Med Chem; 2014 Jun; 6(10):1167-78. PubMed ID: 25078136
[TBL] [Abstract][Full Text] [Related]
35. Switching of pyruvate kinase isoform L to M2 promotes metabolic reprogramming in hepatocarcinogenesis.
Wong CC; Au SL; Tse AP; Xu IM; Lai RK; Chiu DK; Wei LL; Fan DN; Tsang FH; Lo RC; Wong CM; Ng IO
PLoS One; 2014; 9(12):e115036. PubMed ID: 25541689
[TBL] [Abstract][Full Text] [Related]
36. PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis.
Liu F; Ma F; Wang Y; Hao L; Zeng H; Jia C; Wang Y; Liu P; Ong IM; Li B; Chen G; Jiang J; Gong S; Li L; Xu W
Nat Cell Biol; 2017 Nov; 19(11):1358-1370. PubMed ID: 29058718
[TBL] [Abstract][Full Text] [Related]
37. Structural basis of PKM2 regulation.
Yang W
Protein Cell; 2015 Apr; 6(4):238-40. PubMed ID: 25773278
[No Abstract] [Full Text] [Related]
38. Dihydroartemisinin represses esophageal cancer glycolysis by down-regulating pyruvate kinase M2.
Li S; Huang P; Gan J; Ling X; Du X; Liao Y; Li L; Meng Y; Li Y; Bai Y
Eur J Pharmacol; 2019 Jul; 854():232-239. PubMed ID: 31004604
[TBL] [Abstract][Full Text] [Related]
39. Role of PKM2 in directing the metabolic fate of glucose in cancer: a potential therapeutic target.
van Niekerk G; Engelbrecht AM
Cell Oncol (Dordr); 2018 Aug; 41(4):343-351. PubMed ID: 29797241
[TBL] [Abstract][Full Text] [Related]
40. Mechanistic and Structural Insights into Cysteine-Mediated Inhibition of Pyruvate Kinase Muscle Isoform 2.
Srivastava D; Nandi S; Dey M
Biochemistry; 2019 Sep; 58(35):3669-3682. PubMed ID: 31386812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]